Trial Profile
Statins IN TREATMENT OF ACUTE coronary syndrome. COMPARISON OF EFFICACY BETWEEN Atorvastatin and Rosuvastatin IN PATIENTS UNDERGO A PTCA THROUGH THE MONITORING OF C REACTIVE PROTEIN
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2012
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 22 Mar 2012 New trial record